相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy and safety of autologous hematopoietic cell transplantation in elderly patients with multiple myeloma: a retrospective national multi-site cohort study
Yael C. Cohen et al.
ANNALS OF HEMATOLOGY (2017)
In-Hospital Mortality and Post-Transplantation Complications in Elderly Multiple Myeloma Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation: A Population-Based Study
Larysa Sanchez et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
Myeloma in the Real World: What Is Really Happening?
Krystal Bergin et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2017)
Autologous stem cell transplant for multiple myeloma patients 70 years or older
E. Muchtar et al.
BONE MARROW TRANSPLANTATION (2016)
Survival of elderly patients with multiple myeloma-Effect of upfront autologous stem cell transplantation
Maximilian Merz et al.
EUROPEAN JOURNAL OF CANCER (2016)
Autotransplant with and without induction chemotherapy in older multiple myeloma patients: long-term outcome of a randomized trial
Christian Straka et al.
HAEMATOLOGICA (2016)
Upfront autologous stem cell transplantation for newly diagnosed elderly multiple myeloma patients: a prospective multicenter study
Laurent Garderet et al.
HAEMATOLOGICA (2016)
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
Shaji Kumar et al.
LANCET ONCOLOGY (2016)
Autotransplant with and without induction chemotherapy in older multiple myeloma patients: long-term outcome of a randomized trial
Christian Straka et al.
HAEMATOLOGICA (2016)
Upfront autologous stem cell transplantation for newly diagnosed elderly multiple myeloma patients: a prospective multicenter study
Laurent Garderet et al.
HAEMATOLOGICA (2016)
High-dose therapy and autologous stem cell transplant in older adults with multiple myeloma
T. M. Wildes et al.
BONE MARROW TRANSPLANTATION (2015)
Trends in autologous hematopoietic cell transplantation for multiple myeloma in Europe: increased use and improved outcomes in elderly patients in recent years
H. W. Auner et al.
BONE MARROW TRANSPLANTATION (2015)
Survival of Multiple Myeloma Patients Aged 65-70 Years in the Era of Novel Agents and Autologous Stem Cell Transplantation
Shuji Ozaki et al.
ACTA HAEMATOLOGICA (2014)
Autologous stem cell transplantation for elderly patients with newly diagnosed multiple myeloma in the era of novel agents
M. Merz et al.
ANNALS OF ONCOLOGY (2014)
Older Patients with Myeloma Derive Similar Benefit from Autologous Transplantation
Manish Sharma et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
S. Vincent Rajkumar et al.
LANCET ONCOLOGY (2014)
Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients
S. K. Kumar et al.
LEUKEMIA (2014)
Autologous Stem Cell Transplantation in Elderly Patients with Multiple Myeloma: Past, Present, and Future
Shuji Ozaki et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Trends in Utilization and Outcomes of Autologous Transplantation as Early Therapy for Multiple Myeloma
Luciano J. Costa et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Management of Newly Diagnosed Symptomatic Multiple Myeloma: Updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines 2013
Joseph R. Mikhael et al.
MAYO CLINIC PROCEEDINGS (2013)
Feasibility of autologous hematopoietic stem cell transplant in patients aged ≥70 years with multiple myeloma
Qaiser Bashir et al.
LEUKEMIA & LYMPHOMA (2012)
Patterns of Multiple Myeloma During the Past 5 Decades: Stable Incidence Rates for All Age Groups in the Population but Rapidly Changing Age Distribution in the Clinic
Ingemar Turesson et al.
MAYO CLINIC PROCEEDINGS (2010)
Autologous stem cell transplantation in patients of 70 years and older with multiple myeloma: Results from a matched pair analysis
Shaji K. Kumar et al.
AMERICAN JOURNAL OF HEMATOLOGY (2008)
Recent major improvement in long-term survival of younger patients with multiple myeloma
Hermann Brenner et al.
BLOOD (2008)
Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trial
Thierry Facon et al.
LANCET (2007)
Patterns of survival in multiple myeloma:: A population-based study of patients diagnosed in Sweden from 1973 to 2003
Sigurdur Yngvi Kristinsson et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Autologous transplantation in elderly patients with multiple myeloma: are we asking the right questions?
H. D. Klepin et al.
BONE MARROW TRANSPLANTATION (2006)
International staging system for multiple myeloma
PR Greipp et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Multiple myeloma: comparison of two dose-intensive melphalan regimens (100 vs 200 mg/m(2))
A Palumbo et al.
LEUKEMIA (2004)
Intermediate-dose melphalan improves survival of myeloma patients aged 50 to 70: results of a randomized controlled trial
A Palumbo et al.
BLOOD (2004)
High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma
JA Child et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Autologous stem cell transplantation in elderly multiple myeloma patients over the age of 70 years
A Badros et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
The role of autologous transplantation in patients with multiple myeloma aged 65 years and over
B Sirohi et al.
BONE MARROW TRANSPLANTATION (2000)
分享论文
